company background image
KRKG logo

Krka d. d LJSE:KRKG Stock Report

Last Price

€133.50

Market Cap

€4.1b

7D

-4.0%

1Y

13.1%

Updated

23 Jun, 2024

Data

Company Financials +

KRKG Stock Overview

A generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally.

KRKG fundamental analysis
Snowflake Score
Valuation4/6
Future Growth1/6
Past Performance2/6
Financial Health6/6
Dividends4/6

Krka, d. d. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Krka d. d
Historical stock prices
Current Share Price€133.50
52 Week High€144.00
52 Week Low€100.00
Beta0.52
11 Month Change4.71%
3 Month Change2.69%
1 Year Change13.14%
33 Year Change28.37%
5 Year Change112.58%
Change since IPO1,583.17%

Recent News & Updates

Krka d. d (LJSE:KRKG) Will Pay A Larger Dividend Than Last Year At €7.50

Jun 11
Krka d. d (LJSE:KRKG) Will Pay A Larger Dividend Than Last Year At €7.50

Recent updates

Krka d. d (LJSE:KRKG) Will Pay A Larger Dividend Than Last Year At €7.50

Jun 11
Krka d. d (LJSE:KRKG) Will Pay A Larger Dividend Than Last Year At €7.50

Are Investors Undervaluing Krka, d. d. (LJSE:KRKG) By 38%?

Jan 31
Are Investors Undervaluing Krka, d. d. (LJSE:KRKG) By 38%?

There's Reason For Concern Over Krka, d. d.'s (LJSE:KRKG) Price

Jan 09
There's Reason For Concern Over Krka, d. d.'s (LJSE:KRKG) Price

Is Krka, d. d. (LJSE:KRKG) Trading At A 24% Discount?

Aug 05
Is Krka, d. d. (LJSE:KRKG) Trading At A 24% Discount?

Krka d. d (LJSE:KRKG) Is Increasing Its Dividend To €6.60

Jul 14
Krka d. d (LJSE:KRKG) Is Increasing Its Dividend To €6.60

Does Krka d. d (LJSE:KRKG) Deserve A Spot On Your Watchlist?

May 24
Does Krka d. d (LJSE:KRKG) Deserve A Spot On Your Watchlist?

Krka d. d (LJSE:KRKG) Has Announced That It Will Be Increasing Its Dividend To €6.60

Apr 09
Krka d. d (LJSE:KRKG) Has Announced That It Will Be Increasing Its Dividend To €6.60

Krka, d. d.'s (LJSE:KRKG) Intrinsic Value Is Potentially 25% Above Its Share Price

Jan 27
Krka, d. d.'s (LJSE:KRKG) Intrinsic Value Is Potentially 25% Above Its Share Price

Is There An Opportunity With Krka, d. d.'s (LJSE:KRKG) 48% Undervaluation?

Oct 26
Is There An Opportunity With Krka, d. d.'s (LJSE:KRKG) 48% Undervaluation?

Here's Why We Think Krka d. d (LJSE:KRKG) Might Deserve Your Attention Today

Aug 30
Here's Why We Think Krka d. d (LJSE:KRKG) Might Deserve Your Attention Today

Krka d. d (LJSE:KRKG) Is Paying Out A Larger Dividend Than Last Year

Jun 24
Krka d. d (LJSE:KRKG) Is Paying Out A Larger Dividend Than Last Year

Is Now The Time To Put Krka d. d (LJSE:KRKG) On Your Watchlist?

May 19
Is Now The Time To Put Krka d. d (LJSE:KRKG) On Your Watchlist?

Krka d. d's (LJSE:KRKG) Upcoming Dividend Will Be Larger Than Last Year's

Apr 28
Krka d. d's (LJSE:KRKG) Upcoming Dividend Will Be Larger Than Last Year's

If You Like EPS Growth Then Check Out Krka d. d (LJSE:KRKG) Before It's Too Late

Feb 14
If You Like EPS Growth Then Check Out Krka d. d (LJSE:KRKG) Before It's Too Late

Are Investors Undervaluing Krka, d. d. (LJSE:KRKG) By 49%?

Nov 24
Are Investors Undervaluing Krka, d. d. (LJSE:KRKG) By 49%?

Here's Why We Think Krka d. d (LJSE:KRKG) Is Well Worth Watching

Oct 30
Here's Why We Think Krka d. d (LJSE:KRKG) Is Well Worth Watching

Are Investors Undervaluing Krka, d. d. (LJSE:KRKG) By 49%?

Aug 11
Are Investors Undervaluing Krka, d. d. (LJSE:KRKG) By 49%?

Increases to Krka, d. d.'s (LJSE:KRKG) CEO Compensation Might Cool off for now

Jul 02
Increases to Krka, d. d.'s (LJSE:KRKG) CEO Compensation Might Cool off for now

Are Investors Undervaluing Krka, d. d. (LJSE:KRKG) By 43%?

Mar 30
Are Investors Undervaluing Krka, d. d. (LJSE:KRKG) By 43%?

Is It Worth Buying Krka, d. d. (LJSE:KRKG) For Its 4.4% Dividend Yield?

Mar 11
Is It Worth Buying Krka, d. d. (LJSE:KRKG) For Its 4.4% Dividend Yield?

Krka, d. d.'s (LJSE:KRKG) Stock Has Fared Decently: Is the Market Following Strong Financials?

Feb 22
Krka, d. d.'s (LJSE:KRKG) Stock Has Fared Decently: Is the Market Following Strong Financials?

What You Need To Know About Krka, d. d.'s (LJSE:KRKG) Investor Composition

Feb 03
What You Need To Know About Krka, d. d.'s (LJSE:KRKG) Investor Composition

Shareholders Of Krka d. d (LJSE:KRKG) Must Be Happy With Their 93% Return

Jan 14
Shareholders Of Krka d. d (LJSE:KRKG) Must Be Happy With Their 93% Return

Calculating The Fair Value Of Krka, d. d. (LJSE:KRKG)

Dec 27
Calculating The Fair Value Of Krka, d. d. (LJSE:KRKG)

Does Krka, d. d. (LJSE:KRKG) Have A Place In Your Dividend Portfolio?

Dec 09
Does Krka, d. d. (LJSE:KRKG) Have A Place In Your Dividend Portfolio?

Could The Market Be Wrong About Krka, d. d. (LJSE:KRKG) Given Its Attractive Financial Prospects?

Nov 20
Could The Market Be Wrong About Krka, d. d. (LJSE:KRKG) Given Its Attractive Financial Prospects?

Shareholder Returns

KRKGSI PharmaceuticalsSI Market
7D-4.0%-0.1%-1.1%
1Y13.1%19.9%24.2%

Return vs Industry: KRKG underperformed the SI Pharmaceuticals industry which returned 19.9% over the past year.

Return vs Market: KRKG underperformed the SI Market which returned 24.2% over the past year.

Price Volatility

Is KRKG's price volatile compared to industry and market?
KRKG volatility
KRKG Average Weekly Movement2.3%
Pharmaceuticals Industry Average Movement5.0%
Market Average Movement2.8%
10% most volatile stocks in SI Market3.0%
10% least volatile stocks in SI Market2.3%

Stable Share Price: KRKG has not had significant price volatility in the past 3 months.

Volatility Over Time: KRKG's weekly volatility (2%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
195412,675Jože Colaricwww.krka.si

Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. Its prescription pharmaceuticals include medicines for the treatment of cardiovascular, alimentary tract and metabolism, central nervous system, infections, oncology, and other diseases. The company also provides non-prescription products for oral cavity and pharynx; cough and cold; analgesics; nasal products; vitamin and mineral products; products for enhancing cerebral and peripheral circulation; products for enhancing digestive tract and digestion; health care products; and others.

Krka, d. d. Fundamentals Summary

How do Krka d. d's earnings and revenue compare to its market cap?
KRKG fundamental statistics
Market cap€4.11b
Earnings (TTM)€323.81m
Revenue (TTM)€1.83b

12.7x

P/E Ratio

2.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
KRKG income statement (TTM)
Revenue€1.83b
Cost of Revenue€807.30m
Gross Profit€1.03b
Other Expenses€703.25m
Earnings€323.81m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Jul 18, 2024

Earnings per share (EPS)10.51
Gross Margin55.99%
Net Profit Margin17.65%
Debt/Equity Ratio0%

How did KRKG perform over the long term?

See historical performance and comparison

Dividends

5.6%

Current Dividend Yield

72%

Payout Ratio

Does KRKG pay a reliable dividends?

See KRKG dividend history and benchmarks
When do you need to buy KRKG by to receive an upcoming dividend?
Krka d. d dividend dates
Ex Dividend DateJul 23 2024
Dividend Pay DateJul 25 2024
Days until Ex dividend30 days
Days until Dividend pay date32 days

Does KRKG pay a reliable dividends?

See KRKG dividend history and benchmarks
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.